Cognoa’s digital diagnostic platform is on track to be the first product cleared by US FDA for early diagnosis of autistic spectrum disorder (ASD).
The system applies machine learning and predictive analytics to diagnostic data and information provided by parents to allow pediatricians and primary care physicians to accurately diagnose ASD in young children....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?